Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dr. Reddy's Laboratories Ltd Common Stock (NY:RDY)

13.48 -0.29 (-2.11%)
Official Closing Price Updated: 4:10 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dr. Reddy's Laboratories Ltd Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
DrReddy's Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript ↗
RDY earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Full News Day ↗
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
News headline image
Banned Merger ↗
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 131.41% to $7.22 during Tuesday's pre-market session. The company's market cap stands at $51.2... 
Via Benzinga
News headline image
Joblessness Surprise ↗
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Fireworks Display ↗
The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Highs On Friday ↗
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs. Interesting Facts: The largest company by market cap to set a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
News headline image
New Month And Half Year ↗
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up. 
Via Talk Markets
News headline image
Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F
From Dr. Reddy’s Laboratories Limited
Via Business Wire
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
This morning 158 companies set new 52-week highs. Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a new 52-week high. The... 
Via Benzinga
News headline image
Moderna Stock Surges To Record High As Covid Battle Rages In India ↗
Moderna stock surged to a record high Tuesday after its Covid vaccine protected against a handful of variants in an early-phase study. 
Via Investor's Business Daily
News headline image
Saint Warren ↗
Today the WTI oil price rose further up over 1%. 
Via Talk Markets
News headline image
Crazy Thursday ↗
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
News headline image
Why Amarin Fell Again Today ↗
Another Vascepa generic is launched in the U.S. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Reconsidered Boom ↗
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
News headline image
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
Two Rate Hikes In 2023 ↗
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
Via Benzinga
News headline image
Fan Hit ↗
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
News headline image
More Inflationary Pressures ↗
Today, we saw more evidence of worrying inflationary pressures from the personal consumption index hitting 3.1% in April over prior April, up sharply from the March rise of 1.9%. 
Via Talk Markets
News headline image
Sterling At Five-Year High ↗
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
News headline image
Worldwide Upbeat ↗
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
News headline image
Tourism Trouble ↗
Today stock markets globally moved into the red, because of mounting fear of inflation along with China's crackdown on crypto-currencies. 
Via Talk Markets
News headline image
Another Tough Day For Markets ↗
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” 
Via Talk Markets
News headline image
Friday Of The Heavy Week ↗
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
News headline image
Dr Reddy's Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose ↗
Dr. Reddy's Laboratories Ltd (NYSE: RDY) said that it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the next couple of months under its... 
Via Benzinga
News headline image
Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.